First-line Antimetabolites as Steroid-sparing Treatment Uveitis Pilot Trial

NCT01232920 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Uveitis

Interventions

DRUG: Methotrexate
DRUG: Mycophenolate mofetil

Sponsor

University of California, San Francisco

Collaborators

[object Object]